Beta-2 receptor drugs to help damaged kidneys recover
The role of beta agonists in the treatment of chronic kidney disease
Seeing if medicines that stimulate beta-2 adrenergic receptors can help people with chronic kidney disease, especially when podocyte injury is involved, recover kidney function.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ralph H Johnson VA Medical Center NIH-funded |
| Lab location | 1 site (Charleston, United States) |
| Project ID | NIH-11212766 on NIH RePORTER |
What this research studies
This project focuses on damaged podocytes, the specialized kidney cells that are often involved in chronic kidney disease, and tests whether activating the beta-2 adrenergic receptor can speed recovery. Researchers will use laboratory and animal models and analyze gene activity linked to mitochondrial function to validate the beta-2 receptor as a treatment target. The work builds on earlier findings that beta-2 signaling can accelerate glomerular recovery after injury and aims to identify molecular pathways that could be targeted by drugs. If successful, the team will have stronger evidence to move toward human testing of beta-2–targeted therapies.
Who could benefit from this research
Good fit: Ideal candidates would be people with chronic kidney disease caused by podocyte or glomerular injury (for example diabetic kidney disease) who are not yet on dialysis.
Not a fit: People with end-stage kidney disease already on dialysis or whose kidney damage stems from unrelated causes may not benefit from this approach.
Why it matters
Potential benefit: If successful, this could lead to new drugs that restore podocyte structure and improve kidney function in people with chronic kidney disease.
How similar studies have performed: Preclinical lab and animal studies have shown promising results for beta-2 receptor activation in speeding kidney recovery, but human benefit has not yet been demonstrated.
Where this research is happening
Charleston, United States
- Ralph H Johnson VA Medical Center — Charleston, United States (Active)
Researchers
- Principal investigator: Lipschutz, Joshua H — Ralph H Johnson VA Medical Center
- Study coordinator: Lipschutz, Joshua H
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.